FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617335718> ?p ?o ?g. }

• W2617335718 endingPage "1661" @default.
• W2617335718 startingPage "1657" @default.
• W2617335718 abstract "Trimetazidine (TMZ) improves clinical outcomes in patients with chronic heart failure and stable coronary artery disease. No study has yet evaluated the efficacy of TMZ in type 2 diabetes patients with acute myocardial infarction (AMI) undergoing Percutaneous Coronary Intervention (PCI). We performed this study to evaluate the efficacy TMZ in DM patients with AMI undergoing PCI, such as the effect on reductions in myocardial enzyme, improvements in liver function, modulation of glucose levels, and improvement in cardiac function. For this randomized study, we enrolled 173 AMI patients with type 2 diabetes undergoing PCI between January 1, 2014, and January 1, 2016. All patients received aspirin and ticagrelor upon admission and throughout their hospitalization. Patients in the experimental group were treated with a loading dose of 60 mg TMZ at admission, and 20 mg TMZ three times a day thereafter. 89 patients were included in experimental group, and 84 patients were included in control group. All patients received PCI treatments. The endpoints evaluated were serum creatine kinase and its isoenzyme (CK and CK-MB), cardiac troponin I (cTNI), serum creatinine (Cr), serum urea, blood glucose, serum glutamic pyruvic transaminase (ALT), serum glutamic oxaloacetictransaminase (AST), left atrial dimension (LA), left ventricular ejection fraction (LVEF), left ventricular end-diastolic dimension (LVEDD), and cardiac output (CO). Compared with the control group, TMZ treatment significantly reduced CK and CK-MB on the second day in hospital ([797 ± 582] vs. [1092 ± 1114]; [80 ± 60] vs. [105 ± 100]; p = 0.029, p = 0.041, respectively), and cTNI after one and six days in hospital ([13.5 ± 12.7] vs. [19.8 ± 19.2]; [3.3 ± 3.2] vs. [4.8 ± 4.7]; two-tailed p = 0.012). In addition, TMZ significantly lowered liver enzymes (ALT, AST) at 6 days ([29.0 ± 11.6] vs. [42.4 ± 24.5]; [39.8 ± 17.3] vs. [69.2 ± 70.0]; two-tailed p = 0.000), lowered glucose after 6 days ([6.80 ± 2.12] vs. [7.59 ± 2.24]; p = 0.019), and increased LVEF after ten to fourteen days ([58.4 ± 8.6] vs. [54.9 ± 8.4]; p = 0.008). There were no significant effect on Cr and serum urea (p = 0.988, p = 0.569, respectively), nor on LA, LVEDD, and CO ([36.3 ± 4.5] vs. [37.0 ± 4.1], p = 0.264; [52.0 ± 4.9] vs. [53.1 ± 4.6], p = 0.128; [5.4 ± 0.9] vs. [5.4 ± 0.9], p = 0.929, respectively). Among type 2 diabetic patients with AMI undergoing PCI, TMZ significantly reduces serum myocardial enzyme, improves liver function, adjusts blood glucose and improves cardiac function." @default.
• W2617335718 created "2017-06-05" @default.
• W2617335718 creator A5002470401 @default.
• W2617335718 creator A5022434416 @default.
• W2617335718 creator A5026699023 @default.
• W2617335718 creator A5039959844 @default.
• W2617335718 creator A5050166540 @default.
• W2617335718 creator A5064247618 @default.
• W2617335718 creator A5067400352 @default.
• W2617335718 creator A5089027641 @default.
• W2617335718 date "2017-11-01" @default.
• W2617335718 modified "2023-09-27" @default.
• W2617335718 title "The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI" @default.
• W2617335718 cites W1571718974 @default.
• W2617335718 cites W1936833235 @default.
• W2617335718 cites W1946331435 @default.
• W2617335718 cites W1966602838 @default.
• W2617335718 cites W1970516435 @default.
• W2617335718 cites W1980114153 @default.
• W2617335718 cites W1981254311 @default.
• W2617335718 cites W1991385182 @default.
• W2617335718 cites W2004785282 @default.
• W2617335718 cites W2017615202 @default.
• W2617335718 cites W2053519943 @default.
• W2617335718 cites W2054267691 @default.
• W2617335718 cites W2067694085 @default.
• W2617335718 cites W2070717530 @default.
• W2617335718 cites W2092069233 @default.
• W2617335718 cites W2096409056 @default.
• W2617335718 cites W2102590431 @default.
• W2617335718 cites W2103432726 @default.
• W2617335718 cites W2105397247 @default.
• W2617335718 cites W2106455559 @default.
• W2617335718 cites W2111397931 @default.
• W2617335718 cites W2117581987 @default.
• W2617335718 cites W2126830306 @default.
• W2617335718 cites W2135319342 @default.
• W2617335718 cites W2166950143 @default.
• W2617335718 cites W2239638001 @default.
• W2617335718 cites W2527192969 @default.
• W2617335718 cites W4292172722 @default.
• W2617335718 doi "https://doi.org/10.1016/j.ajem.2017.05.024" @default.
• W2617335718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28587952" @default.
• W2617335718 hasPublicationYear "2017" @default.
• W2617335718 type Work @default.
• W2617335718 sameAs 2617335718 @default.
• W2617335718 citedByCount "13" @default.
• W2617335718 countsByYear W26173357182019 @default.
• W2617335718 countsByYear W26173357182020 @default.
• W2617335718 countsByYear W26173357182021 @default.
• W2617335718 countsByYear W26173357182022 @default.
• W2617335718 countsByYear W26173357182023 @default.
• W2617335718 crossrefType "journal-article" @default.
• W2617335718 hasAuthorship W2617335718A5002470401 @default.
• W2617335718 hasAuthorship W2617335718A5022434416 @default.
• W2617335718 hasAuthorship W2617335718A5026699023 @default.
• W2617335718 hasAuthorship W2617335718A5039959844 @default.
• W2617335718 hasAuthorship W2617335718A5050166540 @default.
• W2617335718 hasAuthorship W2617335718A5064247618 @default.
• W2617335718 hasAuthorship W2617335718A5067400352 @default.
• W2617335718 hasAuthorship W2617335718A5089027641 @default.
• W2617335718 hasConcept C115725540 @default.
• W2617335718 hasConcept C126322002 @default.
• W2617335718 hasConcept C164705383 @default.
• W2617335718 hasConcept C2777698277 @default.
• W2617335718 hasConcept C2777785093 @default.
• W2617335718 hasConcept C2777927741 @default.
• W2617335718 hasConcept C2778198053 @default.
• W2617335718 hasConcept C2778213512 @default.
• W2617335718 hasConcept C2780400711 @default.
• W2617335718 hasConcept C45393284 @default.
• W2617335718 hasConcept C500558357 @default.
• W2617335718 hasConcept C71924100 @default.
• W2617335718 hasConcept C78085059 @default.
• W2617335718 hasConceptScore W2617335718C115725540 @default.
• W2617335718 hasConceptScore W2617335718C126322002 @default.
• W2617335718 hasConceptScore W2617335718C164705383 @default.
• W2617335718 hasConceptScore W2617335718C2777698277 @default.
• W2617335718 hasConceptScore W2617335718C2777785093 @default.
• W2617335718 hasConceptScore W2617335718C2777927741 @default.
• W2617335718 hasConceptScore W2617335718C2778198053 @default.
• W2617335718 hasConceptScore W2617335718C2778213512 @default.
• W2617335718 hasConceptScore W2617335718C2780400711 @default.
• W2617335718 hasConceptScore W2617335718C45393284 @default.
• W2617335718 hasConceptScore W2617335718C500558357 @default.
• W2617335718 hasConceptScore W2617335718C71924100 @default.
• W2617335718 hasConceptScore W2617335718C78085059 @default.
• W2617335718 hasIssue "11" @default.
• W2617335718 hasLocation W26173357181 @default.
• W2617335718 hasLocation W26173357182 @default.
• W2617335718 hasOpenAccess W2617335718 @default.
• W2617335718 hasPrimaryLocation W26173357181 @default.
• W2617335718 hasRelatedWork W1968779297 @default.
• W2617335718 hasRelatedWork W1976624361 @default.
• W2617335718 hasRelatedWork W2009921926 @default.
• W2617335718 hasRelatedWork W2350881416 @default.
• W2617335718 hasRelatedWork W2355614377 @default.
• W2617335718 hasRelatedWork W2372198895 @default.

• next